|
|
|
Volumn 2, Issue 11, 2001, Pages 1564-1567
|
|
Mechanism of action of thiazolidinediones
|
|
Author keywords
Peroxisome proliferator activated receptor ; Pioglitazone; Thiazolidinedione; Type 2 diabetes
|
|
Indexed keywords
2,2 DICHLORO 12 (4 CHLOROPHENYL)DODECANOIC ACID;
2,4 THIAZOLIDINEDIONE DERIVATIVE;
5 (2,4 DIOXO 5 THIAZOLIDINYLMETHYL) 2 METHOXY N [4 (TRIFLUOROMETHYL)BENZYL]BENZAMIDE;
ALPHA GLUCOSIDASE INHIBITOR;
CALCIUM CHANNEL BLOCKING AGENT;
CARBOHYDRATE;
CIGLITAZONE;
DARGLITAZONE;
ENGLITAZONE;
FARGLITAZAR;
GW 0072;
HEMOGLOBIN A1C;
INSULIN;
KETOCONAZOLE;
LIPID;
METFORMIN;
MEVINOLIN;
NC 2100;
NETOGLITAZONE;
ORAL ANTIDIABETIC AGENT;
ORAL CONTRACEPTIVE AGENT;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PIOGLITAZONE;
REGLITAZAR;
ROSIGLITAZONE;
SIMVASTATIN;
SULFONYLUREA;
TROGLITAZONE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANEMIA;
ATHEROGENESIS;
BODY WEIGHT DISORDER;
CARBOHYDRATE METABOLISM;
CARCINOGENESIS;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DIABETES CONTROL;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG CLASSIFICATION;
DRUG CONTRAINDICATION;
DRUG DESIGN;
DRUG EFFICACY;
DRUG FATALITY;
DRUG HALF LIFE;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG MONITORING;
DRUG PREFERENCE;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
EDEMA;
HUMAN;
HYPERTENSION;
INFLAMMATION;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIPID METABOLISM;
LIVER FAILURE;
METABOLIC DISORDER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PROTEIN LOCALIZATION;
REVIEW;
TOXICITY TESTING;
WEIGHT GAIN;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
THIAZOLES;
THIAZOLIDINEDIONES;
|
|
EID: 0035182222
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (26)
|
